Stevens Capital Management LP Nuvasive Inc Transaction History

Stevens Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 08, 2019	SELL	$55.78 - $68.08 $387,280 - $472,679	-6,943 Closed	0 $0
Q2 2019 Jul 31, 2019	BUY	$53.69 - $65.47 $372,769 - $454,558	6,943 New	6,943 $406,000
Q4 2018 Feb 06, 2019	SELL	$47.64 - $71.26 $474,256 - $709,393	-9,955 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$52.03 - $71.41 $310,567 - $426,246	5,969 Added 149.75%	9,955 $707,000
Q2 2018 Aug 09, 2018	SELL	$48.15 - $56.68 $857,214 - $1.01 Million	-17,803 Reduced 81.71%	3,986 $208,000
Q1 2018 May 08, 2018	SELL	$46.03 - $61.28 $1.3 Million - $1.73 Million	-28,201 Reduced 56.41%	21,789 $1.14 Million
Q4 2017 Feb 13, 2018	BUY	$50.58 - $60.79 $853,739 - $1.03 Million	16,879 Added 50.98%	49,990 $2.92 Million
Q3 2017 Nov 01, 2017	BUY	$53.54 - $68.0 $1.77 Million - $2.25 Million	33,111	33,111 $1.84 Million

116K

Ticker NUVA
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 52,061,000
Description
NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Stevens Capital Management LP with notifications on news.